ASCO 2022 Conference Coverage

 

ASCO 2022 Conference Coverage
B

Lecture Summary - ASCO 2022 Optimization of the Duration of Adjuvant Endocrine Therapy in Early Breast Cancer

By ASCO 2022 Conference Coverage FEATURING Barbara Pistilli
By ASCO 2022 Conference Coverage FEATURING Barbara Pistilli
19 views
June 13, 2022
0 Comments
Login to view comments. Click here to Login
Breast
54
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 Adjuvant Abemaciclib for High-risk Early…

Feat. S. Tolaney
07:17
ASCO 2022 Conference Coverage

ASCO 2022 Adjuvant Abemaciclib for High-Risk Early Breast Cancer: Fa…

Feat. S. Tolaney
01:10
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 A Phase 1b/2 Study of the BET Inhibitor …

Feat. P. Aftimos
10:53
ASCO 2022 Conference Coverage

ASCO 2022 A Phase 1b/2 Study of the BET Inhibitor ZEN-3694 in Combin…

Feat. P. Aftimos
10:23
ASCO 2022 Conference Coverage

ASCO 2022 Phase 2 Study of Lasofoxifene + Abemaciclib for Treating P…

Feat. S. Damodaran
10:12
ASCO 2022 Conference Coverage

ASCO 2022 on FLEX - the 30,000 Breast Cancer Transcriptome Project: …

Feat. C. Ma
01:04
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 Phase 2 Study of Lasofoxifene + Abemacic…

Feat. S. Damodaran
52
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 on FLEX - the 30,000 Breast Cancer Trans…

Feat. C. Ma
01:17
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 on Monitoring and Management of Intersti…

Feat. B. Feinberg
11:56
ASCO 2022 Conference Coverage

ASCO 2022 on Monitoring and Management of Interstitial Lung Disease/…

Feat. B. Feinberg
04:01
ASCO 2022 Conference Coverage

ASCO 2022 on Sacituzumab Govitecan vs. Treatment of Physician’s Choi…

Feat. A. Bardia
43
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 on Sacituzumab Govitecan vs. Treatment o…

Feat. A. Bardia
09:57
ASCO 2022 Conference Coverage

ASCO 2022 Preliminary Analysis of an Expanded Access Study of the Fi…

Feat. C. Dang
01:06
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 Preliminary Analysis of an Expanded Acce…

Feat. C. Dang
06:19
ASCO 2022 Conference Coverage

ASCO 2022 Phase 2 Study of Response-Guided Neoadjuvant Sacituzumab G…

Feat. L. Spring
48
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 Phase 2 Study of Response-Guided Neoadj…

Feat. L. Spring
04:16
ASCO 2022 Conference Coverage

ASCO 2022 Analyses From PALOMA-2: Overall Survival With 1L Palbocicl…

Feat. D. Slamon
03:10
ASCO 2022 Conference Coverage

ASCO 2022 Neoadjuvant HER2-Targeted Therapy +/- Immunotherapy With P…

Feat. H. McArthur
04:36
ASCO 2022 Conference Coverage

ASCO 2022 A Single-Arm, Phase 2 Study of Perioperative Ipi, Nivo, an…

Feat. H. McArthur
56
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 Neoadjuvant HER2-Targeted Therapy +/- Im…

Feat. H. McArthur
37
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 A Single-Arm, Phase 2 Study of Periopera…

Feat. H. McArthur
50
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 on a Randomized Phase II/III PARTNER Tri…

Feat. R. Lucey
05:52
ASCO 2022 Conference Coverage

ASCO 2022 on a Randomized Phase II/III PARTNER Trial to Evaluate the…

Feat. R. Lucey
43
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 Overall Survival With 1L Palbociclib + L…

Feat. D. Slamon
03:41
ASCO 2022 Conference Coverage

ASCO 2022 Adherence to EndoPredict Test Scores for Extended ET Manag…

Feat. A. Brufsky
47
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 Adherence to EndoPredict Test Scores for…

Feat. A. Brufsky
01:03
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 on EFS by Residual Cancer Burden After N…

Feat. L. Pusztai
13:17
ASCO 2022 Conference Coverage

ASCO 2022 on EFS by Residual Cancer Burden After Neoadjuvant Pembro …

Feat. L. Pusztai
05:13
ASCO 2022 Conference Coverage

ASCO 2022 Optimization of the Duration of Adjuvant Endocrine Therapy…

Feat. B. Pistilli
34
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 Trastuzumab Deruxtecan vs. Trastuzumab E…

Feat. E. Hamilton
28
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 Optimization of the Duration of Adjuvant…

Feat. B. Pistilli
44
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 Impact of BMI on Treatment and Outcomes …

Feat. G. Pfeiler
43
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 on Alpelisib + Continued ET Following Pr…

Feat. C. Truica
04:56
ASCO 2022 Conference Coverage

ASCO 2022 Impact of BMI on Treatment and Outcomes in Patients With H…

Feat. G. Pfeiler
06:50
ASCO 2022 Conference Coverage

ASCO 2022 on Alpelisib + Continued ET Following Progression on ET in…

Feat. C. Truica
04:28
ASCO 2022 Conference Coverage

ASCO 2022 Subgroup Analysis of Patients With No Prior Chemo in Phase…

Feat. V. Kaklamani
30
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 Subgroup Analysis of Patients With No Pr…

Feat. V. Kaklamani
01:18
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 Survival Outcomes in Metastatic HR+, HER…

Feat. J. Mouabbi
09:18
ASCO 2022 Conference Coverage

ASCO 2022 Survival Outcomes in Metastatic HR+, HER2- IDC Compared to…

Feat. J. Mouabbi
31
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 on NRG-BR007: A Phase III Trial Evaluati…

Feat. J. White
10:55
ASCO 2022 Conference Coverage

ASCO 2022 on NRG-BR007: A Phase III Trial Evaluating De-Escalation o…

Feat. J. White
01:21
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 on the Type of ET and DFS in Early HER2+…

Feat. M. Vittoria Dieci
06:57
ASCO 2022 Conference Coverage

ASCO 2022 on the Type of ET and DFS in Early HER2+/HR+ BC: Analysis …

Feat. M. Vittoria Dieci
49
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022: The ImPrint Immune Signature to Identif…

Feat. L. Mittempergher
11:09
ASCO 2022 Conference Coverage

ASCO 2022: The ImPrint Immune Signature to Identify Patients With Hi…

Feat. L. Mittempergher
32
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 on Estradiol Levels in Premenopausal Wom…

Feat. M. Tesch
10:19
ASCO 2022 Conference Coverage

ASCO 2022 on Estradiol Levels in Premenopausal Women With HR+ BC on …

Feat. M. Tesch
01:37
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 on Characterization of Alpelisib-Associa…

Feat. S. Shen
06:32
ASCO 2022 Conference Coverage

ASCO 2022 on Characterization of Alpelisib-Associated Hyperglycemia …

Feat. S. Shen
27
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 on Disparity Between Ki67 Measurements …

Feat. R. Stein
08:04
ASCO 2022 Conference Coverage

ASCO 2022 on OPTIMA Preliminary Trial: Disparity Between Ki67 Measur…

Feat. R. Stein